Leukemia, Myeloid, Chronic-Phase
Showing 9951 - 9975 of >10,000
Alcohol Use Disorder Trial in London (BPL-003)
Not yet recruiting
- Alcohol Use Disorder
-
London, United KingdomKing's College London
Dec 21, 2022
Conjunctivitis, Allergic Trial in United States (ADX-102 Ophthalmic Drops (0.5%), ADX-102 Ophthalmic Drops (0.1%), Vehicle of
Completed
- Conjunctivitis, Allergic
- ADX-102 Ophthalmic Drops (0.5%)
- +2 more
-
Morrow, Georgia
- +4 more
Dec 14, 2022
NASH - Nonalcoholic Steatohepatitis Trial in San Antonio (TERN-501, TERN-101, Placebo)
Recruiting
- NASH - Nonalcoholic Steatohepatitis
- TERN-501
- +2 more
-
Chandler, Arizona
- +21 more
Jan 6, 2023
Chronic Insomnia Trial in France (Cryo-Auriculotherapy, Sham comparator)
Recruiting
- Chronic Insomnia
- Cryo-Auriculotherapy
- Sham comparator
-
Issy-les-Moulineaux, Hauts De Seine, France
- +3 more
Jan 20, 2022
Advanced Solid Tumor Trial (SHR-A2009)
Recruiting
- Advanced Solid Tumor
-
Beijing, Beijing, ChinaChinese PLA General Hospital-Department of Medical Oncology
Oct 20, 2022
Treatment Resistant Depression Trial in United States (Liafensine, Placebo)
Recruiting
- Treatment Resistant Depression
- Liafensine
- Placebo
-
Huntsville, Alabama
- +23 more
Oct 4, 2022
Brain Metastases, Adult Trial (Hypofractionated Radiosurgery (HSRS), Brain metastases surgical resection)
Not yet recruiting
- Brain Metastases, Adult
- Hypofractionated Radiosurgery (HSRS)
- Brain metastases surgical resection
- (no location specified)
Oct 4, 2022
Autosomal Dominant Polycystic Kidney Disease (ADPKD) Trial in Korea, Republic of (Tolvaptan)
Completed
- Autosomal Dominant Polycystic Kidney Disease (ADPKD)
-
Busan, Korea, Republic of
- +17 more
Jun 15, 2022
Maintenance With Bortezomib Plus Daratumumab After Induction
Recruiting
- Multiple Myeloma
- Non-eligible for Autologous Stem Cell Transplantation (ASCT)
-
Arganda Del Rey, Spain
- +31 more
Sep 15, 2022
Fibromyalgia Trial in United States (TNX-102 SL, Placebo SL Tablet)
Recruiting
- Fibromyalgia
- TNX-102 SL
- Placebo SL Tablet
-
Phoenix, Arizona
- +34 more
Dec 21, 2022
Stage III/IV Melanoma Trial in Worldwide (tavokinogene telseplasmid, Pembrolizumab, ImmunoPulse)
Recruiting
- Stage III/IV Melanoma
- tavokinogene telseplasmid
- +2 more
-
Tucson, Arizona
- +37 more
Dec 21, 2022
Platinum-resistant Ovarian Cancer, Endometrial Adenocarcinoma, Urothelial Carcinoma Trial in Canton (ACR-368, Gemcitabine,
Recruiting
- Platinum-resistant Ovarian Cancer
- +2 more
- ACR-368
- +2 more
-
Mobile, Alabama
- +7 more
Jan 24, 2023
Insomnia Trial in New York (Digital cognitive behavioral therapy for insomnia (CBT-I) program, Minimally Enhanced Usual Care
Recruiting
- Insomnia
- Digital cognitive behavioral therapy for insomnia (CBT-I) program
- +2 more
-
New York, New YorkColumbia School of Social Work
Sep 16, 2022
Chronic Pain, Depression, Anxiety, Sleep Trial in Northampton (Neurofeedback training)
Completed
- Chronic Pain
- +3 more
- Neurofeedback training
-
Northampton, United KingdomEast Midlands Spine Ltd
Mar 21, 2022
Rhinosinusitis Trial in Al Qurayyat (Sniff Relief Sinus Mask, Ultrasound Therapy, Manual Drainage Techniques)
Recruiting
- Rhinosinusitis
- Sniff Relief Sinus Mask
- +3 more
-
Al Qurayyat, Jouf Region, Saudi ArabiaAl Qurayyat General Hospital
Jun 30, 2022
Gliomas Trial in New York (Topotecan, Gadolinium, Synchromed II infusion pumps)
Completed
- Gliomas
- Topotecan
- +2 more
-
New York, New YorkColumbia University Irving Medical Center
Jun 30, 2022
Metabolic Syndrome Trial (Aromatherapy)
Not yet recruiting
- Metabolic Syndrome
- Aromatherapy
- (no location specified)
Aug 3, 2023
PREDICT: Thinking About Pregnancy Risk in Kidney Disease
Recruiting
- Chronic Kidney Diseases
- Pregnancy Related
-
London, Greater London, United KingdomElizabeth Ralston
Sep 2, 2021
Autism, Autism Spectrum Disorder Trial in Durham (Cord Tissue Mesenchymal Stromal Cells, Placebo Infusion)
Active, not recruiting
- Autism
- Autism Spectrum Disorder
- Cord Tissue Mesenchymal Stromal Cells
- Placebo Infusion
-
Durham, North CarolinaDuke University Medical Center
Oct 26, 2022
Locally Advanced (Inoperable) or Metastatic Breast Cancer Trial in Worldwide (Capivasertib, Matched Capivasertib Placebo,
Recruiting
- Locally Advanced (Inoperable) or Metastatic Breast Cancer
- Capivasertib
- +3 more
-
Los Angeles, California
- +76 more
Nov 25, 2022
Tumors, Fatigue Trial in Bilthoven, Groningen (Samen Minder Moe (Dutch intervention name))
Recruiting
- Neoplasms
- Fatigue
- Samen Minder Moe (Dutch intervention name)
-
Bilthoven, Netherlands
- +1 more
Dec 2, 2022